About OptimizeRx

Steve Silvestro brings more than 20 years’ experience in direct operations, sales, and partner network growth, to lead revenue activities and strengthen the go-to-market.

Steve is responsible for driving OptimizeRx's platform revenue growth including enterprise-level direct-to-patient and direct-to-provider product adoption to improve patient outcomes.
‍
During his tenure at Decision Resources Group, he was an instrumental leader in the growth of the company from $30 million to $180 million in revenue. His customer-first philosophy is greatly aligned to our values at OptimizeRx.
‍
Steve previously served as vice president and general manager at CCH Tagetik, a division of Wolters Kluwer. Prior pharma leadership experience includes executive positions with Prognos, Decision Resources Group and D.M.S. Silvestro has extensive channel expertise in biopharma commercialization, global market access, market research, analytics, enterprise SaaS solutions and strategy.
‍
Silvestro received a master’s degree in Business Management from Harvard University. He also holds undergraduate degrees from Brigham Young University in both Business and Italian. He is fluent in English, Italian, Spanish and conversational in French.

A seasoned leader with a passion for innovation in healthcare, Theresa brings over 25 years of experience driving commercial success. Her expertise spans healthcare data, analytics, technology, and consulting services.

In October 2023, she joined OptimizeRx as its Chief Commercial Officer following the Company’s acquisition of Healthy Offers, Inc. (“Medicx Health”), where she served as President. Previously, Theresa held Chief Commercial Officer positions at leading healthcare companies such as MediSpend and Prognos Health where she led product strategy, marketing, sales, and customer delivery.

Her career includes notable roles at LexisNexis Healthcare, where she contributed to revenue growth and profitability. Additionally, she led the Life Sciences consulting group at Computer Sciences Corporation and held various positions at IQVIA and Pfizer.  

Theresa holds a Master of Business Administration in Healthcare Administration Management from Temple University. She completed her undergraduate studies at Ursinus College, earning a Bachelor of Science degree.

Ed has over 30 years of diverse experience at organizations going through transformational changes, including international expansions, new product launches, financial/operational turnarounds, mergers & acquisitions, resource prioritization, strategy creation, and digital innovation. In his senior leadership roles, Ed has continually brought lasting positive culture changes and purpose to the organizations he serves.

Prior to joining OptimizeRx Ed served in a variety of leadership roles at Otsuka America Pharmaceuticals Inc. His tenure with Otsuka began as a CFO leading the finance team on a transformative journey to help steer the organization through Abilify loss of exclusivity (LOE). It culminated in an appointment as CFO/COO to lead a ~400 person, multi-functional team of professionals through product lifecycle management, new product launches, strategy development, alliance governance, M&A and COVID-19 response. Over his tenure, the US organization evolved to be one of the best performing businesses for Otsuka globally and built best-in-class capabilities across a number of key enterprise functions through significant process optimization and automation initiatives.

Ed’s career has taken him across the globe, including foreign expat assignments in the Netherlands and Russia. He has held positions of increasing responsibilities in finance and operations at Covance/LabCorp, Mylan, Organon/Schering-Plough, Sanofi-Aventis and Johnson & Johnson.

Outside of work, Ed serves as the Treasurer and Executive Committee member of the American Foundation of Suicide Prevention in NYC, and as a member of the Advisory Committee of the Arts Council of Princeton.

He received his Bachelor of Science in Finance from Towson University and his MBA from the University of Baltimore. He is also a Certified Public Accountant (inactive) in the State of New Jersey and a Certified Management Accountant. He is married with two adult children, and fluent in Russian.

Marion is a corporate lawyer with over 25 years of large firm and in-house experiences in a broad range of industries including life sciences, biotech, high tech, business consulting, professional services, banking and finance companies. She is a critical thinker with strong global management, leadership, analytical, communication and problem-solving skills with emphasis on providing practical and proactive solutions to complex legal and business issues in both the domestic and international arenas.

Marion oversees the Compliance/Corporate Governance, and Legal/Contracts teams. Her areas of expertise include corporate, mergers and acquisitions and securities; complex transactions and global commercial contracts; privacy and IT security compliance; technology and licensing; labor and employment; corporate policy development and training; and corporate governance and board relations.

Prior to joining OptimizeRx, Marion worked in various leadership roles in both public and private companies. She began her legal career in private practice at the Boston law firm of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, PC, where she advised public and private companies on corporate matters.

Marion received her J.D. from Northeastern University, her M.Phil from the University of Cambridge, and her B.A. from Columbia University. Marion lives in Cambridge, Massachusetts, is married, has two adult children, and is fluent in Korean and proficient in Italian.

Dr. Doug Besch has nearly 20 years of experience in healthcare leadership. Throughout his career, Doug has demonstrated expertise in product strategy and innovation within the healthcare industry.

Prior to his current role, he served as the Vice President of Market Access & Payer Solutions for Clarivate and Vice President of Payor Product & Innovation at Decision Resources Group. In these positions, he was instrumental in setting product vision and strategy, aligning cross-functional teams, and securing investments for strategic initiatives.
‍
Dr. Besch was a co-founder and the Chief Product Officer for Rx Savings Solution, a company that helps members and payers reduce prescription drug costs through a combination of clinical technology, transparency, member engagement, and concierge support. His professional journey began as a pharmacist for the Walgreens Boots Alliance.  
‍
Dr. Besch holds a Doctor of Pharmacy (PharmD) degree and a Master of Business Administration from Creighton University, complemented by a Bachelor of Science from Simpson College.

A seasoned financial leader with a strong background in healthcare and capital markets, Andy D'Silva brings nearly 15 years of experience driving growth and strategic transformation. His expertise spans corporate finance, business development, investor relations, and M&A, with a proven track record of helping organizations optimize capital allocation and create long-term shareholder value.
‍
Andy joined the Company in 2021 and has played a critical role in shaping its financial strategy and growth trajectory. Prior to his current role as Chief Business Officer, he served as Senior Vice President of Corporate Finance, where he oversaw FP&A, investor relations, and supported the Company’s M&A activities in collaboration with senior leadership.
‍
Earlier in his career, Andy was a Senior Healthcare Research Analyst at B. Riley Securities and a Managing Director on Merriman Capital’s equity research team, where he developed deep expertise in healthcare equity markets. He began his career in the construction industry as a Project Manager, working closely with real estate development companies.
‍
Andy holds a bachelor’s degree in Economics from the University of California, San Diego.

Brendan brings 15+ years of healthcare operations, customer success and sales leadership experience. Delivering results for colleagues, customers and organizations served.  
‍
Joining OptimizeRx in 2020, Brendan performed roles of increasing responsibility in operational and commercial leadership. Prior to his current role serving as Senior Vice President of Client Strategy and Program Management. In this capacity he led the transformation of multiple functions to drive organizational focus and measurable advancement in operational excellence and operating leverage.  
‍
Brendan spent the 9+ years prior in life sciences strategic decision-support. Leading teams partnering with top pharmaceutical manufacturers provisioning data informing portfolio and brand investment strategies, culminating in his role at DRG as Senior Vice President and Head of Commercial Excellence. Throughout each phase of his career in leadership, Brendan has brought together and enabled engaged, high performing teams, direct and cross-functional.  
‍
Brendan holds a Bachelor of Arts degree from Union College in Schenectady, NY.